Medicine & Life Sciences
Peru
100%
Enterotoxigenic Escherichia coli
93%
Diarrhea
85%
Escherichia coli
72%
miglustat
66%
Child
63%
Shiga Toxin 2
59%
Shiga-Toxigenic Escherichia coli
58%
Norovirus
48%
colonization factor antigens
31%
Cattle
30%
Caliciviridae Infections
28%
Endothelial Cells
27%
Epithelial Cells
27%
Virulence Factors
24%
Pediatrics
24%
Lactoferrin
23%
Social Security
23%
Gangliosides
23%
Argentina
22%
Cholera Toxin
22%
Gastroenteritis
20%
Kidney
20%
Hemolytic-Uremic Syndrome
20%
Surface Antigens
19%
Health Insurance
19%
Coinfection
18%
Cohort Studies
16%
ceramide glucosyltransferase
15%
Shiga Toxin 1
15%
Swine
14%
G(M1) Ganglioside
14%
Multiplex Polymerase Chain Reaction
14%
HIV
13%
Clinical Trials
12%
Escherichia coli O157
12%
Biomedical Technology Assessment
12%
Phase III Clinical Trials
11%
Contracts
10%
Drug Industry
10%
Real-Time Polymerase Chain Reaction
10%
Enteropathogenic Escherichia coli
10%
Serogroup
9%
Cell Culture Techniques
9%
Acute Kidney Injury
8%
Farms
8%
Chronic Kidney Failure
8%
Sulfamethoxazole Drug Combination Trimethoprim
8%
Ampicillin
8%
Multilocus Sequence Typing
8%
Agriculture & Biology
Peru
58%
pediatrics
47%
enterotoxigenic Escherichia coli
30%
Human immunodeficiency virus
26%
cohort studies
25%
Norovirus
25%
diarrhea
25%
Shiga toxin-producing Escherichia coli
24%
gangliosides
23%
cholera toxin
23%
lactoferrin
23%
gastroenteritis
23%
cattle
22%
antibiotic resistance
18%
Escherichia coli
16%
fluids
14%
pathogens
13%
swine
12%
mice
10%
ampicillin
8%
quantitative polymerase chain reaction
7%
sampling
6%
azithromycin
5%
Shiga toxin
5%
enteropathogenic Escherichia coli
5%
farm numbers
5%
toxins
5%